Reproduction and longevity: A Mendelian randomization study of gonadotropin-releasing hormone and ischemic heart disease
Background: According to well-established evolutionary biology theory there is a trade-off between reproduction and longevity, implying that upregulating the reproductive axis might drive major diseases. We assessed whether the central driver of reproduction gonadotropin-releasing hormone 1 (GnRH1)...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_9823a835a3cb4bcfa462e77eaba83c17 | ||
042 | |a dc | ||
100 | 1 | 0 | |a C.M. Schooling |e author |
700 | 1 | 0 | |a Jack C.M. Ng |e author |
245 | 0 | 0 | |a Reproduction and longevity: A Mendelian randomization study of gonadotropin-releasing hormone and ischemic heart disease |
260 | |b Elsevier, |c 2019-08-01T00:00:00Z. | ||
500 | |a 2352-8273 | ||
500 | |a 10.1016/j.ssmph.2019.100411 | ||
520 | |a Background: According to well-established evolutionary biology theory there is a trade-off between reproduction and longevity, implying that upregulating the reproductive axis might drive major diseases. We assessed whether the central driver of reproduction gonadotropin-releasing hormone 1 (GnRH1) had a causal effect on the leading cause of global morbidity and mortality, i.e. ischemic heart disease (IHD). As a contrast we similarly examined the role of GnRH2 because it is more a driver of female sexual behavior. Methods: We applied strong (p-value <5 × 10−6) and independent genetic predictors of GnRH1 and GnRH2 to an extensively genotyped IHD case (n = 76,014) - control (n = 264,785) study and combined the genetic variant specific Wald estimates using inverse variance weighting (IVW) with multiplicative random effects, and as a sensitivity analysis used weighted median, MR-Egger and MR-PRESSO estimates, and repeated the analysis only using genome wide significant genetic predictors. Findings: GnRH1, predicted by 11 genetic variants, was positively associated with IHD (IVW odds ratio (OR) 1.04 per effect size, 95% confidence interval (CI) 1.01 to 1.08), but GnRH2, predicted by 15 genetic variants, was not (IVW OR 0.98, 95% CI 0.95 to 1.02). Estimates from sensitivity analysis were similar. Interpretation: GnRH1 is a potential IHD genetic target. Apart from demonstrating a central tenet of evolutionary biology in humans, our study suggests that existing treatments and environmental factors targeting GnRH1, its drivers or consequences could be re-purposed to prevent and treat IHD. Given, the importance of reproduction to the human species, many such exposures likely exist. Keywords: GnRH, IHD, Mendelian randomization, Evolutionary biology | ||
546 | |a EN | ||
690 | |a Public aspects of medicine | ||
690 | |a RA1-1270 | ||
690 | |a Social sciences (General) | ||
690 | |a H1-99 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n SSM: Population Health, Vol 8, Iss , Pp - (2019) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S2352827319300904 | |
787 | 0 | |n https://doaj.org/toc/2352-8273 | |
856 | 4 | 1 | |u https://doaj.org/article/9823a835a3cb4bcfa462e77eaba83c17 |z Connect to this object online. |